SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
<p>The most pressing issues of the secondary drug prevention of the most common cardiovascular diseases are focused. These are arterial hypertension, stable ischemic heart disease, chronic<br />heart failure.</p>
Saved in:
Main Authors: | E. V. Filippov (Author), S. S. Yakushin (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015) -
Non-pharmacological secondary prevention of cardiovascular diseases in patients with stable angina at specialized ambulatory institution
by: S. B. Fitilev, et al.
Published: (2018) -
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
by: G. De Backer, et al.
Published: (2015) -
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
by: G. De Backer, et al.
Published: (2015) -
SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY
by: E. V. Filippov, et al.
Published: (2016)